Prof. Anas Younes: Genome sequencing data in clinical practice - ICML 2017
Prof. Anas Younes | ASH 2017 | Addition of BV in the practice of treating advanced HL
An overview of iwNHL 2016 by Prof. Anas Younes
How are drug development and clinical trials changing?
Ask A Scientist: Understanding Blood Cancer
Meeting Highlights - Dr Anas Younes: how to ensure that breakthroughs will happen for NHL/CLL
Gaining a better understanding of lymphoma therapies through mass data collection
Latest research in Hodgkin lymphoma
How is the landscape of Hodgkin lymphoma therapy changing?
An overview of the potential of immunotherapy in treating lymphoma
Novel Therapies in FL: Benefits and Challenges
iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine
What is the focus of lymphoma research in 2017?
The role of epigenetic modulators in the pathogenesis of lymphomas
What makes the British Society for Haematology (BSH) Annual Scientific Meeting unique?
Dr. Younes Discusses the Future of CAR T-Cell Therapy
A summary of lymphoma immune checkpoint inhibitor data at EHA 2017
Dr. Younes on Atezolizumab, Obinutuzumab, and Bendamustine in Follicular Lymphoma
Results for Atezolizumab, Obinutuzumab, and Bendamustine in Follicular Lymphoma
iwNHL 2016: Highlights from Day 2
